<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To describe the sonographic features and pregnancy outcomes of placental mesenchymal <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (PMD), an entity often misdiagnosed as <z:e sem="disease" ids="C0020217" disease_type="Neoplastic Process" abbrv="HYDM">molar pregnancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We reviewed PMD cases from our institution and performed a systematic review of the existing literature </plain></SENT>
<SENT sid="2" pm="."><plain>Inclusion criteria for the review were diagnosis of PMD as defined by placental pathology, description of placental <z:mp ids='MP_0000002'>morphology</z:mp> on antenatal ultrasound and reporting of pregnancy outcomes </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: We found three cases of PMD at our institution </plain></SENT>
<SENT sid="4" pm="."><plain>Patient 1 had elevated human chorionic gonadotropin (hCG) and an enlarged, <z:hpo ids='HP_0011414'>hydropic placenta</z:hpo> at 13â€‰weeks, suggestive of a <z:e sem="disease" ids="C0020217" disease_type="Neoplastic Process" abbrv="HYDM">molar pregnancy</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Patient 2 also had elevated hCG with large, vascular placental lakes on ultrasound suggesting <z:e sem="disease" ids="C0032044" disease_type="Disease or Syndrome" abbrv="">placenta accreta</z:e> or <z:e sem="disease" ids="C0020217" disease_type="Neoplastic Process" abbrv="HYDM">molar pregnancy</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Case 3 involved placentomegaly and fetal anomalies suggestive of <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>From the literature review, 61 cases met the inclusion criteria </plain></SENT>
<SENT sid="8" pm="."><plain>The most common sonographic features included enlarged (50%) and cystic (80%) placenta with dilated chorionic vessels </plain></SENT>
<SENT sid="9" pm="."><plain>Biochemical <z:mp ids='MP_0004024'>aneuploidy</z:mp> screening abnormalities were relatively common as were fetal anomalies, <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> and other genetic abnormalities </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">Pregnancy complications</z:e> included <z:hpo ids='HP_0001511'>intrauterine growth restriction</z:hpo> (IUGR; 33%), intrauterine fetal <z:hpo ids='HP_0011420'>death</z:hpo> (IUFD; 13%), and <z:e sem="disease" ids="C0022876" disease_type="Disease or Syndrome" abbrv="">preterm labor</z:e> (33%) </plain></SENT>
<SENT sid="11" pm="."><plain>Pregnancies without fetal anomalies, IUGR, IUFD or <z:e sem="disease" ids="C0022876" disease_type="Disease or Syndrome" abbrv="">preterm labor</z:e> had <z:mpath ids='MPATH_458'>normal</z:mpath> neonatal outcomes despite PMD (9%) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: The differential diagnosis of PMD includes <z:e sem="disease" ids="C0020217" disease_type="Neoplastic Process" abbrv="HYDM">molar pregnancy</z:e> and other placental vascular anomalies </plain></SENT>
<SENT sid="13" pm="."><plain>PMD is associated with adverse pregnancy outcome, so heightened surveillance with genetic evaluation, serial growth scans and third-trimester assessment of wellbeing should be considered </plain></SENT>
<SENT sid="14" pm="."><plain>PMD must be differentiated from <z:e sem="disease" ids="C1135868" disease_type="Neoplastic Process" abbrv="">gestational trophoblastic disease</z:e> because management and outcomes differ </plain></SENT>
</text></document>